Terry Strom

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Physiology

Anatomy

T-Lymphocytes

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hastings William D; Anderson David E; Kassam Nasim; Koguchi Ken; Greenfield Edward A; Kent Sally C; Zheng Xin Xiao; Strom Terry B; Hafler David A; Kuchroo Vijay K
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.
Strom Terry B
Can childhood viral infection protect from type 1 diabetes?
Mariat Christophe; Degauque Nicolas; Strom Terry B
TIM-1: a new player in transplant immunity.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Terry Strom (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hastings William D; Anderson David E; Kassam Nasim; Koguchi Ken; Greenfield Edward A; Kent Sally C; Zheng Xin Xiao; Strom Terry B; Hafler David A; Kuchroo Vijay K
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.
European journal of immunology 2009;39(9):2492-501.
2009: Strom Terry B
Can childhood viral infection protect from type 1 diabetes?
The Journal of clinical investigation 2009;119(6):1458-61.
2009: Mariat Christophe; Degauque Nicolas; Strom Terry B
TIM-1: a new player in transplant immunity.
Transplantation 2009;87(9 Suppl):S84-6.
2009: Gao Wenda; Thompson Lorraine; Zhou Qiang; Putheti Prabhakar; Fahmy Tarek M; Strom Terry B; Metcalfe Su M
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.
Cell cycle (Georgetown, Tex.) 2009;8(9):1444-50.
2008: Dardalhon Valérie; Awasthi Amit; Kwon Hyoung; Galileos George; Gao Wenda; Sobel Raymond A; Mitsdoerffer Meike; Strom Terry B; Elyaman Wassim; Ho I-Cheng; Khoury Samia; Oukka Mohamed; Kuchroo Vijay K
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
Nature immunology 2008;9(12):1347-55.
2008: Koulmanda Maria; Bhasin Manoj; Hoffman Lauren; Fan Zhigang; Qipo Andi; Shi Hang; Bonner-Weir Susan; Putheti Prabhakar; Degauque Nicolas; Libermann Towia A; Auchincloss Hugh; Flier Jeffrey S; Strom Terry B
Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(42):16242-7.
2008: Rodriguez-Manzanet Roselynn; Meyers Jennifer Hartt; Balasubramanian Savithri; Slavik Jacqueline; Kassam Nasim; Dardalhon Valerie; Greenfield Edward A; Anderson Ana C; Sobel Raymond A; Hafler David A; Strom Terry B; Kuchroo Vijay K
TIM-4 expressed on APCs induces T cell expansion and survival.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(7):4706-13.
2007: Strom Terry B
2006 Homer W. Smith Lecture: taming T cells.
Journal of the American Society of Nephrology : JASN 2007;18(11):2824-32.
2007: Zhong Xuemei; Gao Wenda; Degauque Nicolas; Bai Chunyan; Lu Yan; Kenny James; Oukka Mohamed; Strom Terry B; Rothstein Thomas L
Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells.
European journal of immunology 2007;37(9):2400-4.
2007: Koulmanda Maria; Budo Ejona; Bonner-Weir Susan; Qipo Andi; Putheti Prabhakar; Degauque Nicolas; Shi Hang; Fan Zhigang; Flier Jeffrey S; Auchincloss Hugh; Zheng Xin Xiao; Strom Terry B
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(32):13074-9.
2007: Degauque Nicolas; Mariat Christophe; Kenny James; Sanchez-Fueyo Alberto; Alexopoulos Sophoclis P; Kuchroo Vijay; Zheng Xin-Xiao; Strom Terry B
Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins.
Transplantation 2007;84(1 Suppl):S12-6.
2007: Korn Thomas; Bettelli Estelle; Gao Wenda; Awasthi Amit; Jäger Anneli; Strom Terry B; Oukka Mohamed; Kuchroo Vijay K
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.
Nature 2007;448(7152):484-7.
2007: Deaglio Silvia; Dwyer Karen M; Gao Wenda; Friedman David; Usheva Anny; Erat Anna; Chen Jiang-Fan; Enjyoji Keiichii; Linden Joel; Oukka Mohamed; Kuchroo Vijay K; Strom Terry B; Robson Simon C
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
The Journal of experimental medicine 2007;204(6):1257-65.
2007: Sánchez-Fueyo Alberto; Domenig Christoph M; Mariat Christophe; Alexopoulos Sophoclis; Zheng Xin X; Strom Terry B
Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(6):534-41.
2007: Koyama I; Nadazdin O; Boskovic S; Ochiai T; Smith R N; Sykes M; Sogawa H; Murakami T; Strom T B; Colvin R B; Sachs D H; Benichou G; Cosimi A B; Kawai T
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1055-61.
2007: Korn Thomas; Reddy Jayagopala; Gao Wenda; Bettelli Estelle; Awasthi Amit; Petersen Troels R; Bäckström B Thomas; Sobel Raymond A; Wucherpfennig Kai W; Strom Terry B; Oukka Mohamed; Kuchroo Vijay K
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.
Nature medicine 2007;13(4):423-31.
2006: Ferrari-Lacraz Sylvie; Zheng Xin Xiao; Fueyo Alberto Sanchez; Maslinski Wlodzimierz; Moll Thomas; Strom Terry B
CD8(+) T cells resistant to costimulatory blockade are controlled by an antagonist interleukin-15/Fc protein.
Transplantation 2006;82(11):1510-7.
2006: El Essawy Basset; Otu Hasan H; Choy Bob; Zheng Xin Xiao; Libermann Towia A; Strom Terry B
Proteomic analysis of the allograft response.
Transplantation 2006;82(2):267-74.
2006: Bettelli Estelle; Carrier Yijun; Gao Wenda; Korn Thomas; Strom Terry B; Oukka Mohamed; Weiner Howard L; Kuchroo Vijay K
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Nature 2006;441(7090):235-8.
2006: Koulmanda M; Smith R N; Qipo A; Weir G; Auchincloss H; Strom T B
Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(4):687-96.
2006: Strom Terry B; Suthanthiran Manikkam
Transcriptional profiling to assess the clinical status of kidney transplants.
Nature clinical practice. Nephrology 2006;2(3):116-7.
2006: Zheng Xin Xiao; Gao Wei; Donskoy Elina; Neuberg Manfred; Ruediger Manfred; Strom Terry B; Moll Thomas
An antagonist mutant IL-15/Fc promotes transplant tolerance.
Transplantation 2006;81(1):109-16.
2006: Sánchez-Fueyo Alberto; Sandner Sigrid; Habicht Antje; Mariat Christophe; Kenny James; Degauque Nicolas; Zheng Xin Xiao; Strom Terry B; Turka Laurence A; Sayegh Mohamed H
Specificity of CD4+CD25+ regulatory T cell function in alloimmunity.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(1):329-34.
2005: Zhu Chen; Anderson Ana C; Schubart Anna; Xiong Huabao; Imitola Jaime; Khoury Samia J; Zheng Xin Xiao; Strom Terry B; Kuchroo Vijay K
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.
Nature immunology 2005;6(12):1245-52.
2005: Sho Masayuki; Kishimoto Koji; Harada Hiroshi; Livak Mauren; Sanchez-Fueyo Alberto; Yamada Akira; Zheng Xin Xiao; Strom Terry B; Basadonna Giacomo P; Sayegh Mohamed H; Rothstein David M
Requirements for induction and maintenance of peripheral tolerance in stringent allograft models.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(37):13230-5.
2005: Mariat Christophe; Sánchez-Fueyo Alberto; Alexopoulos Sophoclis P; Kenny James; Strom Terry B; Zheng Xin Xiao
Regulation of T cell dependent immune responses by TIM family members.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2005;360(1461):1681-5.
2005: Chakravarti Sumone; Sabatos Catherine A; Xiao Sheng; Illes Zsolt; Cha Eugene K; Sobel Raymond A; Zheng Xin X; Strom Terry B; Kuchroo Vijay K
Tim-2 regulates T helper type 2 responses and autoimmunity.
The Journal of experimental medicine 2005;202(3):437-44.
2005: Domenig Christoph; Sanchez-Fueyo Alberto; Kurtz Josef; Alexopoulos Sophoclis P; Mariat Christophe; Sykes Megan; Strom Terry B; Zheng Xin Xiao
Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(1):51-60.
2005: Avihingsanon Yingyos; Ma Naili; Pavlakis Martha; Chon W James; Uknis Marc E; Monaco Anthony P; Ferran Christiane; Stillman Isaac; Schachter Asher D; Mottley Christina; Zheng Xin Xiao; Strom Terry B
On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.
Journal of the American Society of Nephrology : JASN 2005;16(6):1542-8.
2005: Meyers Jennifer Hartt; Chakravarti Sumone; Schlesinger David; Illes Zsolt; Waldner Hanspeter; Umetsu Sarah E; Kenny James; Zheng Xin Xiao; Umetsu Dale T; DeKruyff Rosemarie H; Strom Terry B; Kuchroo Vijay K
TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation.
Nature immunology 2005;6(5):455-64.
2004: Sánchez-Fueyo Alberto; Strom Terry B
Immunological tolerance and liver transplantation.
Journal of hepatology 2004;41(5):698-705.
2004: Ferrari-Lacraz Sylvie; Zanelli Eric; Neuberg Manfred; Donskoy Elina; Kim Yon Su; Zheng Xin Xiao; Hancock Wayne W; Maslinski Wlodzimierz; Li Xian Chang; Strom Terry B; Moll Thomas
Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5818-26.
2004: Zhong Xuemei; Bai Chunyan; Gao Wenda; Strom Terry B; Rothstein Thomas L
Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger.
International immunology 2004;16(8):1181-8.
2004: Strom Terry B; Field Loren J; Ruediger Manfred
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deployment.
Journal of the American Society of Nephrology : JASN 2004;15(5):1133-9.
2004: Demirci Gülçin; Amanullah Farhana; Kewalaramani Reshma; Yagita Hideo; Strom Terry B; Sayegh Mohamed H; Li Xian Chang
Critical role of OX40 in CD28 and CD154-independent rejection.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1691-8.
2003: Zheng Xin Xiao; Sanchez-Fueyo Alberto; Domenig Christoph; Strom Terry B
The balance of deletion and regulation in allograft tolerance.
Immunological reviews 2003;196():75-84.
2003: Sabatos Catherine A; Chakravarti Sumone; Cha Eugene; Schubart Anna; Sánchez-Fueyo Alberto; Zheng Xin Xiao; Coyle Anthony J; Strom Terry B; Freeman Gordon J; Kuchroo Vijay K
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.
Nature immunology 2003;4(11):1102-10.
2003: Sánchez-Fueyo Alberto; Tian Jane; Picarella Dominic; Domenig Christoph; Zheng Xin Xiao; Sabatos Catherine A; Manlongat Natasha; Bender Orissa; Kamradt Thomas; Kuchroo Vijay K; Gutiérrez-Ramos José-Carlos; Coyle Anthony J; Strom Terry B
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
Nature immunology 2003;4(11):1093-101.
2003: Zheng Xin Xiao; Sánchez-Fueyo Alberto; Sho Masayuki; Domenig Christoph; Sayegh Mohamed H; Strom Terry B
Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance.
Immunity 2003;19(4):503-14.
2003: Demirci Gulcin; Strom Terry B; Li Xian Chang
Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(7):3878-85.
2003: Gao Wenda; Demirci Gülçin; Strom Terry B; Li Xian Chang
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Transplantation 2003;76(6):994-9.
2003: Zheng Xin Xiao; Maslinski Wlodzmierz; Ferrari-Lacraz Sylvie; Strom Terry B
Cytokines in the treatment and prevention of autoimmune responses-a role of IL-15.
Advances in experimental medicine and biology 2003;520():87-95.
2002: Sho Masayuki; Yamada Akira; Najafian Nader; Salama Alan D; Harada Hiroshi; Sandner Sigrid E; Sanchez-Fueyo Alberto; Zheng Xin Xiao; Strom Terry B; Sayegh Mohamed H
Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(7):3744-51.
2002: Strom Terry B; Field Loren J; Ruediger Manfred
Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine.
Current opinion in immunology 2002;14(5):601-5.
2002: Sánchez-Fueyo Alberto; Domenig Christoph; Strom Terry B; Zheng Xin Xiao
The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.
Transplantation 2002;74(6):898-900.
2002: Kurowska Mariola; Rudnicka Weronika; Kontny Ewa; Janicka Iwona; Chorazy Magdalena; Kowalczewski Jacek; Ziólkowska Maria; Ferrari-Lacraz Sylvie; Strom Terry B; Maslinski Wlodzimierz
Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(4):1760-7.
2002: Kishimoto Koji; Sandner Sigrid; Imitola Jaime; Sho Masayuki; Li Yongsheng; Langmuir Peter B; Rothstein David M; Strom Terry B; Turka Laurence A; Sayegh Mohamed H
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.
The Journal of clinical investigation 2002;109(11):1471-9.
2002: Ferrari-Lacraz S; Zheng X X; Kim Y S; Maslinski W; Strom T B
Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.
Transplantation proceedings 2002;34(3):745-7.
2002: Demirci Gülçin; Gao Wenda; Zheng Xin Xiao; Malek Thomas R; Strom Terry B; Li Xian Chang
On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4382-90.
2002: Avihingsanon Yingyos; Ma Naili; Csizmadia Eva; Wang Candace; Pavlakis Martha; Giraldo Mauricio; Strom Terry B; Soares Miguel P; Ferran Christiane
Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection.
Transplantation 2002;73(7):1079-85.
2002: Sánchez-Fueyo Alberto; Weber Martina; Domenig Christoph; Strom Terry B; Zheng Xin Xiao
Tracking the immunoregulatory mechanisms active during allograft tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(5):2274-81.
2002: Strehlau Juergen; Schachter Asher D; Pavlakis Martha; Singh Anup; Tejani Amir; Strom Terry B
Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis.
Kidney international 2002;61(1):90-5.
2001: Strom T B; Field L J; Ruediger M
Allogeneic stem cells, clinical transplantation, and the origins of regenerative medicine.
Transplantation proceedings 2001;33(7-8):3044-9.
2001: Li X C; Wells A D; Turka L A; Strom T B
Death of alloreactive T cells sets the stage for immunoregulation to act.
Transplantation proceedings 2001;33(7-8):3041-3.
2001: Ferrari-Lacraz S; Zheng X X; Kim Y S; Li Y; Maslinski W; Li X C; Strom T B
An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(6):3478-85.
2001: Craiu A; Barouch D H; Zheng X X; Kuroda M J; Schmitz J E; Lifton M A; Steenbeke T D; Nickerson C E; Beaudry K; Frost J D; Reimann K A; Strom T B; Letvin N L
An IL-2/Ig fusion protein influences CD4+ T lymphocytes in naive and simian immunodeficiency virus-infected Rhesus monkeys.
AIDS research and human retroviruses 2001;17(10):873-86.
2001: Wasowska B A; Zheng X X; Strom T B; Kupieck-Weglinski J W
Adjunctive rapamycin and CsA treatment inhibits monocyte/macrophage associated cytokines/chemokines in sensitized cardiac graft recipients.
Transplantation 2001;71(8):1179-83.
2001: Li X C; Strom T B; Turka L A; Wells A D
T cell death and transplantation tolerance.
Immunity 2001;14(4):407-16.
2001: Li X C; Demirci G; Ferrari-Lacraz S; Groves C; Coyle A; Malek T R; Strom T B
IL-15 and IL-2: a matter of life and death for T cells in vivo.
Nature medicine 2001;7(1):114-8.
2000: Zand M S; Li Y; Hancock W; Li X C; Roy-Chaudhury P; Zheng X X; Strom T B
Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts.
Transplantation 2000;70(9):1378-81.
2000: Schachter A D; Strehlau J; Zurakowski D; Vasconcellos L; Kim Y S; Zheng X X; Gunshin Y; Overstreet S L; Benfield M R; Tejani A; Harmon W E; Herrin J T; Strom T B
Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis.
Transplantation 2000;70(7):1107-10.
2000: Dodge I L; Demirci G; Strom T B; Li X C
Rapamycin induces transforming growth factor-beta production by lymphocytes.
Transplantation 2000;70(7):1104-6.
2000: Barouch D H; Santra S; Schmitz J E; Kuroda M J; Fu T M; Wagner W; Bilska M; Craiu A; Zheng X X; Krivulka G R; Beaudry K; Lifton M A; Nickerson C E; Trigona W L; Punt K; Freed D C; Guan L; Dubey S; Casimiro D; Simon A; Davies M E; Chastain M; Strom T B; Gelman R S; Montefiori D C; Lewis M G; Emini E A; Shiver J W; Letvin N L
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
Science (New York, N.Y.) 2000;290(5491):486-92.
2000: Li X C; Wells A D; Strom T B; Turka L A
The role of T cell apoptosis in transplantation tolerance.
Current opinion in immunology 2000;12(5):522-7.
2000: Barouch D H; Craiu A; Kuroda M J; Schmitz J E; Zheng X X; Santra S; Frost J D; Krivulka G R; Lifton M A; Crabbs C L; Heidecker G; Perry H C; Davies M E; Xie H; Nickerson C E; Steenbeke T D; Lord C I; Montefiori D C; Strom T B; Shiver J W; Lewis M G; Letvin N L
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(8):4192-7.
2000: Strom T B; Suthanthiran M
Prospects and applicability of molecular diagnosis of allograft rejection.
Seminars in nephrology 2000;20(2):103-7.
2000: Li X C; Ima A; Li Y; Zheng X X; Malek T R; Strom T B
Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1193-9.
1999: Li Y; Li X C; Zheng X X; Wells A D; Turka L A; Strom T B
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.
Nature medicine 1999;5(11):1298-302.
1999: Hendry W S; Tilney N L; Baldwin W M; Graves M J; Milford E; Strom T B; Carpenter C B
Transfer of specific unresponsiveness to organ allografts by thymocytes.
Journal of the American Society of Nephrology : JASN 1999;10(11):2454-63.
1999: Zheng X X; Steele A W; Hancock W W; Kawamoto K; Li X C; Nickerson P W; Li Y; Tian Y; Strom T B
IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(7):4041-8.
1999: Li X C; Li Y; Dodge I; Wells A D; Zheng X X; Turka L A; Strom T B
Induction of allograft tolerance in the absence of Fas-mediated apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(5):2500-7.
1999: Zheng X X; Markees T G; Hancock W W; Li Y; Greiner D L; Li X C; Mordes J P; Sayegh M H; Rossini A A; Strom T B
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4983-90.
1999: Zheng X X; Li Y; Li X C; Roy-Chaudhury P; Nickerson P; Tian Y; Sayegh M H; Strom T B
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts.
Transplantation proceedings 1999;31(1-2):627-8.
1999: Li X C; Zheng X X; Strom T B
T-cell growth factors in allograft rejection and tolerance.
Transplantation proceedings 1999;31(1-2):342-3.
1998: Kim Y S; Maslinski W; Zheng X X; Schachter A D; Strom T B
Immunoglobulin-cytokine fusion molecules: the new generation of immunomodulating agents.
Transplantation proceedings 1998;30(8):4031-6.
1998: Li Y; Zheng X X; Li X C; Zand M S; Strom T B
Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.
Transplantation 1998;66(10):1387-8.
1998: Vasconcellos L M; Schachter A D; Zheng X X; Vasconcellos L H; Shapiro M; Harmon W E; Strom T B;
Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts.
Transplantation 1998;66(5):562-6.
1998: Li X C; Zand M S; Li Y; Zheng X X; Strom T B
On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(5):2241-7.
1998: Strehlau J; Maslinski W; Chae D; Pavlakis M; Ehrich J H; Strom T B
Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment.
Transplantation proceedings 1998;30(5):2389-91.
1998: Schachter A D; Vasconcellos L; Ophascharoensuk V; Zheng X X; Strehlau J; Strom T B
CTL effector mechanisms: diagnostic applications.
Transplantation proceedings 1998;30(5):2344-6.
1998: Barouch D H; Santra S; Steenbeke T D; Zheng X X; Perry H C; Davies M E; Freed D C; Craiu A; Strom T B; Shiver J W; Letvin N L
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(4):1875-82.
1998: Li X C; Schachter A D; Zand M S; Li Y; Zheng X X; Harmon W E; Strom T B
Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15.
Transplantation 1998;66(2):265-8.
1998: Li X C; Roy-Chaudhury P; Hancock W W; Manfro R; Zand M S; Li Y; Zheng X X; Nickerson P W; Steiger J; Malek T R; Strom T B
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):890-6.
1998: Zheng X X; Schachter A D; Vasconcellos L; Strehlau J; Tian Y; Shapiro M; Harmon W; Strom T B
Increased CD40 ligand gene expression during human renal and murine islet allograft rejection.
Transplantation 1998;65(11):1512-5.
1998: Kim Y S; Maslinski W; Zheng X X; Stevens A C; Li X C; Tesch G H; Kelley V R; Strom T B
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):5742-8.
1998: Basadonna G P; Auersvald L; Khuong C Q; Zheng X X; Kashio N; Zekzer D; Minozzo M; Qian H; Visser L; Diepstra A; Lazarovits A I; Poppema S; Strom T B; Rothstein D M
Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3821-6.
1997: Zhu G; Nicolson A G; Zheng X X; Strom T B; Sukhatme V P
Adenovirus-mediated beta-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli.
Kidney international 1997;52(4):992-9.
1997: Muruve D A; Manfro R C; Strom T B; Libermann T A
Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants.
Transplantation 1997;64(3):542-6.
1997: Zheng X X; Sayegh M H; Zheng X G; Li Y; Linsley P S; Peach R; Borriello F; Strom T B; Sharpe A H; Turka L A
The role of donor and recipient B7-1 (CD80) in allograft rejection.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(3):1169-73.
1997: Roy-Chaudhury P; Nickerson P W; Manfro R C; Zheng X X; Steiger J; Li Y S; Strom T B
CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.
Transplantation 1997;64(1):172-5.
1997: Muruve D A; Nicolson A G; Manfro R C; Strom T B; Sukhatme V P; Libermann T A
Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts.
Human gene therapy 1997;8(8):955-63.
1997: Stevens A C; Matthews J; Andres P; Baffis V; Zheng X X; Chae D W; Smith J; Strom T B; Maslinski W
Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain.
The American journal of physiology 1997;272(5 Pt 1):G1201-8.
1997: Zheng X X; Steele A W; Hancock W W; Stevens A C; Nickerson P W; Roy-Chaudhury P; Tian Y; Strom T B
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(9):4507-13.
1997: Roy-Chaudhury P; Manfro R C; Steiger J; Nickerson P W; Tian Y; Zheng X X; Li Y S; Strom T B
IL-2 and IL-4 double knock-out mice reject islet allografts: a role for novel T-cell growth factors?
Transplantation proceedings 1997;29(1-2):1083-4.
1997: Manfro R C; Roy-Chaudhury P; Zheng X X; Steiger J; Nickerson P W; Li Y; Maslinski W; Strom T B
Interleukin-15 gene transcripts are present in rejecting islet allografts.
Transplantation proceedings 1997;29(1-2):1077-8.
1997: Wasowska B; Hancock W W; Onodera K; Korom S; Stadlbauer T H; Zheng X X; Strom T B; Kupiec-Weglinski J W
Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
Transplantation proceedings 1997;29(1-2):333.
1997: Nickerson P; Steiger J; Zheng X X; Steele A W; Steurer W; Roy-Chaudhury P; Strom T B
Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?
Transplantation 1997;63(4):489-94.
1997: Onodera K; Hancock W W; Graser E; Lehmann M; Sayegh M H; Strom T B; Volk H D; Kupiec-Weglinski J W
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1572-81.
1997: Strehlau J; Pavlakis M; Lipman M; Shapiro M; Vasconcellos L; Harmon W; Strom T B
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):695-700.
1997: Nickerson P; Zheng X X; Steiger J; Steele A W; Steurer W; Roy-Chaudhury P; Müller W; Strom T B
Prolonged islet allograft acceptance in the absence of expression of interleukin-4.
Advances in nephrology from the Necker Hospital 1997;26():171-80.
1996: Almawi W Y; Saouda M S; Stevens A C; Lipman M L; Barth C M; Strom T B
Partial mediation of glucocorticoid antiproliferative effects by lipocortins.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(12):5231-9.
1996: Strom T B; Roy-Chaudhury P; Manfro R; Zheng X X; Nickerson P W; Wood K; Bushell A
The Th1/Th2 paradigm and the allograft response.
Current opinion in immunology 1996;8(5):688-93.
1996: Chae D W; Nosaka Y; Strom T B; Maslinski W
Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(7):2813-9.
1996: Pavlakis M; Strehlau J; Lipman M; Shapiro M; Maslinski W; Strom T B
Intragraft IL-15 transcripts are increased in human renal allograft rejection.
Transplantation 1996;62(4):543-5.
1996: Pavlakis M; Strehlau J; Lipman M; Strom T B
Use of intragraft gene expression in the diagnosis of kidney allograft rejection.
Transplantation proceedings 1996;28(4):2019-21.
1996: Wieder K J; Chatis P; Boltax J; Wieder I; Nuovo G; Strom T B
Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4.
AIDS research and human retroviruses 1996;12(10):867-76.
1996: Nickerson P; Zheng X X; Steiger J; Steele A W; Steurer W; Roy-Chaudhury P; Müller W; Strom T B
Prolonged islet allograft acceptance in the absence of interleukin 4 expression.
Transplant immunology 1996;4(1):81-5.
1996: Pavlakis M; Lipman M; Strom T B
Intragraft expression of T-cell activation genes in human renal allograft rejection.
Kidney international. Supplement 1996;53():S7-12.
1996: Wasowska B; Wieder K J; Hancock W W; Zheng X X; Berse B; Binder J; Strom T B; Kupiec-Weglinski J W
Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(1):395-404.
1996: Barth C; Pavlakis M; Lavery P; Strom T B; Loertscher R
Restricted TCR V beta repertoire in the human mixed lymphocyte reaction is determined by the TCR on the responder cell and not by the stimulating antigen on the stimulator cell.
Transplantation 1996;61(1):133-9.
1995: Shapiro M E; Abrams J M; Brown R S; Steinman T I; Strom T B
Successful pancreas-renal transplantation without anti-T-cell antibody induction.
Transplantation proceedings 1995;27(6):3087-8.
1995: Strom T B; Steele A W; Nichols J
Genetically engineered proteins for immunoregulation.
Transplantation proceedings 1995;27(5 Suppl 1):18-20.
1995: Pavlakis M; Lipman M L; Strom T B
Intragraft T cell receptor transcript expression in human renal allografts.
Journal of the American Society of Nephrology : JASN 1995;6(2):281-5.
1995: Steurer W; Nickerson P W; Steele A W; Steiger J; Zheng X X; Strom T B
Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1165-74.
1995: Steiger J; Nickerson P W; Steurer W; Moscovitch-Lopatin M; Strom T B
IL-2 knockout recipient mice reject islet cell allografts.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(1):489-98.
1995: Zheng X X; Steele A W; Nickerson P W; Steurer W; Steiger J; Strom T B
Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(10):5590-600.
1995: Meisels I S; Strom T B; Roy-Chaudhury P; Abrams J; Shapiro M E
Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome.
Transplantation 1995;59(8):1214-5.
1995: Wasowska B; Wieder K J; Hancock W W; Berse B; Binder J; Strom T B; Kupiec-Weglinski J W
Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Transplantation proceedings 1995;27(1):423-6.
1995: Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn M A; Strom T B
5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
The Journal of pharmacology and experimental therapeutics 1995;272(1):399-406.
1994: Nickerson P; Steurer W; Steiger J; Zheng X; Steele A W; Strom T B
Cytokines and the Th1/Th2 paradigm in transplantation.
Current opinion in immunology 1994;6(5):757-64.
1994: Zheng X X; Strom T B; Steele A W
Quantitative comparison of rapamycin and cyclosporine effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction.
Transplantation 1994;58(1):87-92.
1994: Lipman M L; Stevens A C; Strom T B
Heightened intragraft CTL gene expression in acutely rejecting renal allografts.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(10):5120-7.
1994: Yokoyama H; Zheng X; Strom T B; Kelley V R
B7(+)-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation.
Kidney international 1994;45(4):1105-12.
1994: Nickerson P W; Steurer W; Steiger J; Strom T B
In pursuit of the "holy grail": allograft tolerance.
Kidney international. Supplement 1994;44():S40-9.
1994: Strom T B; Kelley V R; Murphy J R; Nichols J; Woodworth T G
Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Advances in nephrology from the Necker Hospital 1994;23():347-56.
1993: Wieder K J; Hancock W W; Schmidbauer G; Corpier C L; Wieder I; Kobzik L; Strom T B; Kupiec-Weglinski J W
Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(2):1158-66.
1993: Nickerson P; Pacheco-Silva A; O'Connell P J; Steurer W; Kelley V R; Strom T B
Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Transplantation proceedings 1993;25(1 Pt 2):984-5.
1993: Maslinski W; Remillard B; Tsudo M; Strom T B
Interleukin-2 receptor signal transduction: translocation of active serine-threonine kinase Raf-1 from IL-2 receptor into cytosol depends on IL-2-induced tyrosine kinase activation.
Transplantation proceedings 1993;25(1 Pt 1):109-10.
1993: O'Connell P J; Pacheco-Silva A; Nickerson P W; Muggia R A; Bastos M; Kelley V R; Strom T B
Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1093-104.
1993: Strom T B; Kelley V R; Murphy J R; Nichols J; Woodworth T G
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules.
Annual review of medicine 1993;44():343-53.
1992: Strom T B; Kelley V R; Woodworth T G; Murphy J R
Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules.
Immunological reviews 1992;129():131-63.
1992: Strom T B
Molecular immunology and immunopharmacology of allograft rejection.
Kidney international. Supplement 1992;38():S182-7.
1992: Díaz-Gallo C; Moscovitch-Lopatin M; Strom T B; Kelley V R
An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(18):8656-60.
1992: Maslinski W; Remillard B; Tsudo M; Strom T B
Interleukin-2 (IL-2) induces tyrosine kinase-dependent translocation of active raf-1 from the IL-2 receptor into the cytosol.
The Journal of biological chemistry 1992;267(22):15281-4.
1992: Stevens C; Walz G; Singaram C; Lipman M L; Zanker B; Muggia A; Antonioli D; Peppercorn M A; Strom T B
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.
Digestive diseases and sciences 1992;37(6):818-26.
1992: Maslinski W; Murphy J R; Strom T B
Intoxication of high affinity IL-2 receptor positive thymocytes blocks early stages of T cell maturation.
International immunology 1992;4(4):509-17.
1992: Lakkis F; Landgraf B; Wen Z; Strom T B; Murphy J R
Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4.
Protein engineering 1992;5(3):241-8.
1992: Pacheco-Silva A; Bastos M G; Muggia R A; Pankewycz O; Nichols J; Murphy J R; Strom T B; Rubin-Kelley V E
Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
European journal of immunology 1992;22(3):697-702.
1992: Papp I; Wieder K J; Sablinski T; O'Connell P J; Milford E L; Strom T B; Kupiec-Weglinski J W
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(5):1308-14.
1992: Lipman M L; Stevens A C; Bleackley R C; Helderman J H; McCune T R; Harmon W E; Shapiro M E; Rosen S; Strom T B
The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection.
Transplantation 1992;53(1):73-9.
1992: Shapiro M E; Kirkman R L; Kelley V R; Bacha P; Nichols J C; Strom T B
In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents.
Targeted diagnosis and therapy 1992;7():383-93.
1992: Barel D; Brennan D C; Jevnikar A M; Bastos M; Strom T B; Kelley V R
Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: modulation by PGE1 and dietary lipid.
Autoimmunity 1992;13(2):141-9.
1991: Waters C A; Snider C E; Itoh K; Poisson L; Strom T B; Murphy J R; Nichols J C
DAB486IL-2 (IL-2 toxin) selectively inactivates high-affinity IL-2 receptor-bearing human peripheral blood mononuclear cells.
Annals of the New York Academy of Sciences 1991;636():403-5.
1991: Kiyokawa T; Williams D P; Snider C E; Waters C A; Nichols J C; Strom T B; Murphy J R
Protein engineering of DAB-IL-2 fusion toxins to increase biologic potency.
Annals of the New York Academy of Sciences 1991;636():331-9.
1991: Strom T B; Anderson P L; Rubin-Kelley V E; Williams D P; Kiyokawa T; Murphy J R
Immunotoxins and cytokine toxin fusion proteins.
Annals of the New York Academy of Sciences 1991;636():233-50.
1991: Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom T B; Murphy J R
Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
European journal of immunology 1991;21(9):2253-8.
1991: Remillard B; Petrillo R; Maslinski W; Tsudo M; Strom T B; Cantley L; Varticovski L
Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase.
The Journal of biological chemistry 1991;266(22):14167-70.
1991: Tilney N L; Chang A; Milford E L; Whitley W D; Lazarus J M; Ramos E L; Strom T B; Carpenter C B; Kirkman R L
Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Annals of surgery 1991;214(1):42-9.
1991: Almawi W Y; Hadro E T; Strom T B
Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function.
Transplantation 1991;52(1):133-40.
1991: Moscovitch-Lopatin M; Petrillo R J; Pankewycz O G; Hadro E; Bleackley C R; Strom T B; Wieder K J
Interleukin 2 counteracts the inhibition of cytotoxic T lymphocytes by cholera toxin in vitro and in vivo.
European journal of immunology 1991;21(6):1439-44.
1991: Almawi W Y; Lipman M L; Stevens A C; Zanker B; Hadro E T; Strom T B
Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(10):3523-7.
1991: Walz G; Stevens C; Zanker B; Melton L B; Clark S C; Suthanthiran M; Strom T B
The role of interleukin-6 in mitogenic T-cell activation: detection of interleukin-2 heteronuclear RNA by polymerase chain reaction.
Cellular immunology 1991;134(2):511-9.
1991: Pankewycz O; Strom T B; Rubin-Kelley V E
Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
European journal of immunology 1991;21(4):873-9.
1991: Kiyokawa T; Williams D P; Snider C E; Strom T B; Murphy J R
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells.
Protein engineering 1991;4(4):463-8.
1991: O'Connell P J; Pacheco-Silva A; Bastos M; Xu H W; Pankewycz O; Rubin-Kelley V E; Strom T B
Sequential analysis by polymerase chain reaction of mononuclear leukocyte activation-associated transcription in pancreatic islet cell allograft rejection.
Transplantation proceedings 1991;23(1 Pt 1):811-2.
1991: Kirkman R L; Shapiro M E; Carpenter C B; McKay D B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1066-7.
1991: Barth C; O'Connell P; Zanker B; Strom T B
Interleukin-7 (IL-7) and its effect on the expression of the intercellular adhesion molecule (ICAM-1) in T cells.
Transplantation proceedings 1991;23(1 Pt 1):824-5.
1991: Kirkman R L; Shapiro M E; Carpenter C B; McKay D B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Transplantation 1991;51(1):107-13.
1990: Bastos M G; Pankewycz O; Rubin-Kelley V E; Murphy J R; Strom T B
Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(11):3535-9.
1990: Williams D P; Wen Z; Watson R S; Boyd J; Strom T B; Murphy J R
Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194.
The Journal of biological chemistry 1990;265(33):20673-7.
1990: Strom T B; Anderson P L; Rubin-Kelley V E; Williams D P; Kiyokawa T; Murphy J R
Immunotoxins and cytokine toxin fusion proteins.
Seminars in immunology 1990;2(6):467-79.
1990: Williams D P; Snider C E; Strom T B; Murphy J R
Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.
The Journal of biological chemistry 1990;265(20):11885-9.
1990: Walz G; Zanker B; Barth C; Wieder K J; Clark S C; Strom T B
Transcriptional modulation of human IL-6 gene expression by verapamil.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4242-8.
1990: Mackie J D; Pankewycz O G; Bastos M G; Kelley V E; Strom T B
Dose-related mechanisms of immunosuppression mediated by murine anti-CD3 monoclonal antibody in pancreatic islet cell transplantation and delayed-type hypersensitivity.
Transplantation 1990;49(6):1150-4.
1990: Wieder K J; Walz G; Zanker B; Sehajpal P; Sharma V K; Skolnik E; Strom T B; Suthanthiran M
Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction.
Cellular immunology 1990;128(1):41-51.
1990: Waters C A; Schimke P A; Snider C E; Itoh K; Smith K A; Nichols J C; Strom T B; Murphy J R
Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
European journal of immunology 1990;20(4):785-91.
1990: Pankewycz O G; Yui M; Kelley V E; Strom T B
The cascading, interrelated roles of interleukin-1, interleukin-2, and interleukin-6 in murine anti-CD3-driven T cell proliferation.
Clinical immunology and immunopathology 1990;55(1):67-85.
1990: Walz G; Zanker B; Murphy J R; Strom T B
A kinetic analysis of the effects of interleukin-2 diphtheria toxin fusion protein upon activated T cells.
Transplantation 1990;49(1):198-201.
1990: Zanker B; Walz G; Wieder K J; Strom T B
Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells.
Transplantation 1990;49(1):183-5.
1990: Walz G; Zanker B; Melton L B; Suthanthiran M; Strom T B
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine.
Transplantation 1990;49(1):191-4.
1989: Walz G; Zanker B; Brand K; Waters C; Genbauffe F; Zeldis J B; Murphy J R; Strom T B
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9485-8.
1989: Shapiro M E; Reed M H; Strom T B; Carpenter C B; Milford E L; Kirkman R L
The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):58-60.
1989: Carpenter C B; Kirkman R L; Shapiro M E; Milford E L; Tiney N L; Waldmann T A; Zimmerman C E; Ramos E L; Strom T B
Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1989;14(5 Suppl 2):54-7.
1989: Ramos E L; Milford E L; Kirkman R L; Tilney N L; Strom T B; Shapiro M E; Waldmann T A; Wood I G; Rollins M R; Carpenter C B
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.
Transplantation 1989;48(3):415-20.
1989: Kelley V E; Kirkman R L; Bastos M; Barrett L V; Strom T B
Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine.
Transplantation 1989;48(1):98-102.
1989: Diamantstein T; Kupiec-Weglinski J W; Strom T B; Tilney N L
Current stage of interleukin 2 receptor targeted therapy.
Experimental and clinical endocrinology 1989;93(2-3):114-24.
1989: Strom T B; Kelley V E
Toward more selective therapies to block undesired immune responses.
Kidney international 1989;35(4):1026-33.
1989: Pankewycz O; Strom T B; Kelley V E
Therapeutic strategies using monoclonal antibodies in autoimmune disease.
Current opinion in immunology 1989;1(4):757-63.
1989: Zanker B; Walz G; Wieder K J; Moscovitch-Lopatin M; Smith B R; Strom T B
Verapamil selectively inhibits expression of interleukin-2 messenger RNA in mitogen activated mononuclear blood cells.
Transplantation proceedings 1989;21(1 Pt 1):85-7.
1989: Kelley V E; Mackie J; Strom T B
Cyclosporin A plus fish oil: accentuate the positive, eliminate the negative.
Transplantation proceedings 1989;21(1 Pt 1):848-9.
1989: Kirkman R L; Shapiro M E; Carpenter C B; Milford E L; Ramos E L; Tilney N L; Waldmann T A; Zimmerman C E; Strom T B
Early experience with anti-Tac in clinical renal transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1766-8.
1989: Barrett L V; Murphy J R; Strom T B; Kirkman R L
Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice.
Transplantation proceedings 1989;21(1 Pt 1):1130-1.
1989: Reed M H; Shapiro M E; Strom T B; Carpenter C B; Letvin N L; Reimann K; Weinberg D S; Waldmann T A; Kirkman R L
Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
Transplantation proceedings 1989;21(1 Pt 1):1028-30.
1989: Walz G; Zanker B; Wieder K; Hadro E; Moscovitch-Lopatin M; Smith B R; Strom T B
Similar effects of cyclosporine and verapamil on lymphokine, interleukin 2 receptor, and proto-oncogene expression.
Transplantation 1989;47(2):331-4.
1989: Kirkman R L; Bacha P; Barrett L V; Forte S; Murphy J R; Strom T B
Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein.
Transplantation 1989;47(2):327-30.
1989: Melton L B; Lakkis F; Moscovitch-Lopatin M; Smith B R; Williams J M; Rosoff P M; Strom T B
Antibody valence and induced signal transduction: the role of antibody valence in anti-CD3-induced signal transduction in isolated normal T cells.
Clinical immunology and immunopathology 1989;50(2):171-83.
1989: Mackie J D; Pankewycz O G; Hassarjian R; Murphy J R; Kelley V E; Strom T B
Immunotherapy using interleukin-2 diphtheria toxin chimer prolongs murine allografts.
Transplantation proceedings 1989;21(1 Pt 3):2718-9.
1989: Pankewycz O; Mackie J; Hassarjian R; Murphy J R; Strom T B; Kelley V E
Interleukin-2-diphtheria toxin fusion protein prolongs murine islet cell engraftment.
Transplantation 1989;47(2):318-22.
1989: Reed M H; Shapiro M E; Strom T B; Milford E L; Carpenter C B; Weinberg D S; Reimann K A; Letvin N L; Waldmann T A; Kirkman R L
Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
Transplantation 1989;47(1):55-9.
1989: Ramos E L; Leggat J E; Milford E L; Kirkman R L; Tilney N L; Strom T B; Shapiro M E; Waldmann T A; Carpenter C B
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.
Transactions of the Association of American Physicians 1989;102():231-9.
1988: Leichtman A B; Strom T B
Therapeutic approach to renal transplantation: triple therapy and beyond.
Transplantation proceedings 1988;20(6 Suppl 8):1-6.
1988: Tilney N L; Padberg W M; Lord R H; Araneda D; Strom T B; Kupiec-Weglinski J W
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipients.
Transplantation 1988;46(2 Suppl):122S-128S.
1988: Tilney N L; Strom T B; Kupiec-Weglinski J W
Pharmacologic and immunologic agonists and antagonists of cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):13-22.
1988: Kelley V E; Bacha P; Pankewycz O; Nichols J C; Murphy J R; Strom T B
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):3980-4.
1988: Strom T B
The cellular and molecular basis of allograft rejection: what do we know?
Transplantation proceedings 1988;20(2):143-6.
1988: Pankewycz O G; Hassarjian R; Chang C; Strom T B; Kelley V E
Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity.
Journal of autoimmunity 1988;1(2):119-30.
1988: Kupiec-Weglinski J W; Hahn H J; Kirkman R L; Volk H D; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris P J; Strom T B
Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
Transplantation proceedings 1988;20(2 Suppl 2):207-16.
1988: Bacha P; Williams D P; Waters C; Williams J M; Murphy J R; Strom T B
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
The Journal of experimental medicine 1988;167(2):612-22.
1988: Murphy J R; Kelley V E; Strom T B
Interleukin 2 toxin: a step toward selective immunomodulation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):159-62.
1988: Kelley V E; Gaulton G N; Hattori M; Ikegami H; Eisenbarth G; Strom T B
Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(1):59-61.
1988: Loertscher R; Leichtman A B; Williams J M; Strom T B
Blocking of T cell activation at the G1A/G1B interface of the cell cycle and prevention of expression of interleukin 2 receptors by alloactivated suppressor T lymphocytes.
Transplantation 1988;45(1):194-201.
1988: Murphy J R; Williams D P; Bacha P; Bishai W; Waters C; Strom T B
Cell receptor specific targeted toxins: genetic construction and characterization of an interleukin 2 diphtheria toxin-related fusion protein.
Journal of receptor research 1988;8(1-4):467-80.
1988: Diamantstein T; Mouzaki A; Osawa H; Volk H D; Hahn H J; Kirkman R L; Strom T B; Tilney N L; Kupiec-Weglinski J W
Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
Developments in biological standardization 1988;69():177-84.
1987: Williams D P; Parker K; Bacha P; Bishai W; Borowski M; Genbauffe F; Strom T B; Murphy J R
Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.
Protein engineering 1987;1(6):493-8.
1987: Tilney N L; Strom T B; Kupiec-Weglinski J W
Humoral and cellular mechanisms in acute allograft injury.
The Journal of pediatrics 1987;111(6 Pt 2):1000-3.
1987: Knudsen P J; Dinarello C A; Strom T B
Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(12):4129-34.
1987: Loertscher R; Abbud-Filho M; Leichtman A B; Ythier A A; Williams J M; Carpenter C B; Strom T B
Differential effect of gamma-irradiated and heat-treated lymphocytes on T cell activation, and interleukin-2 and interleukin-3 release in the human mixed lymphocyte reaction.
Transplantation 1987;44(5):673-80.
1987: Padberg W M; Di Stefano R; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L; Kupiec-Weglinski J W
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation.
Transplantation proceedings 1987;19(5):4234-5.
1987: Padberg W M; Lord R H; Kupiec-Weglinski J W; Williams J M; Di Stefano R; Thornburg L E; Araneda D; Strom T B; Tilney N L
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1751-7.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Ma L; Lord R H; Araneda D; Strom T B; Diamantstein T; Tilney N L
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
European journal of immunology 1987;17(3):313-9.
1987: Kelley V E; Strom T B
Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
Transplantation proceedings 1987;19(1 Pt 1):617.
1987: Strom T B
The immunopharmacology of graft rejection.
Transplantation proceedings 1987;19(1 Pt 1):128-9.
1987: Milford E L; Carpenter C B; Kirkman R L; Tilney N L; Mazoujian G; Strom T B; Lazarus J M; Schlossman S F; Guttmann R D; Lowry R
Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
Transplantation proceedings 1987;19(1 Pt 3):1910.
1987: Shapiro M E; Kirkman R L; Reed M H; Puskas J D; Mazoujian G; Letvin N L; Carpenter C B; Milford E L; Waldmann T A; Strom T B
Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
Transplantation proceedings 1987;19(1 Pt 1):594-8.
1987: Kupiec-Weglinski J W; Padberg W; Uhteg L C; Towpik E; Lord R H; Ma L; Diamantstein T; Strom T B; Tilney N L
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
Transplantation proceedings 1987;19(1 Pt 1):591-3.
1987: Melton L B; Lakkis F G; Deloria D; Williams J W; Strom T B
Requirements for primary T cell activation.
Transplantation proceedings 1987;19(1 Pt 1):331-2.
1987: Murphy J R; Bishai W; Williams D; Bacha P; Borowski M; Parker K; Boyd J; Waters C; Strom T B
Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteins.
Biochemical Society symposium 1987;53():9-23.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom T B; Tilney N L
Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
Transplantation 1986;42(2):191-6.
1986: Schneider T M; Kupiec-Weglinski J W; Towpik E; Strom T B; Tilney N L
Studies on mechanisms of acute rejection of vascularized organ allografts.
Human immunology 1986;15(3):320-9.
1985: Heidecke C D; Araujo J L; Kupiec-Weglinski J W; Abbud-Filho M; Araneda D; Stadler J; Siewert J; Strom T B; Tilney N L
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.
Transplantation 1985;40(4):441-4.
1985: Ythier A A; Abbud-Filho M; Williams J M; Loertscher R; Schuster M W; Nowill A; Hansen J A; Maltezos D; Strom T B
Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):7020-4.
1985: Kupiec-Weglinski J W; Heidecke C D; Araujo J L; Abbud-Filho M; Towpik E; Araneda D; Strom T B; Tilney N L
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
Cellular immunology 1985;93(1):168-77.
1984: Abbud-Filho M; Kupiec-Weglinski J W; Araujo J L; Heidecke C D; Tilney N L; Strom T B
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2582-6.
1984: Heidecke C D; Kupiec-Weglinski J W; Lear P A; Abbud-Filho M; Araujo J L; Araneda D; Strom T B; Tilney N L
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):582-8.
1984: Tilney N L; Kupiec-Weglinski J W; Heidecke C D; Lear P A; Strom T B
Mechanisms of rejection and prolongation of vascularized organ allografts.
Immunological reviews 1984;77():185-216.
1983: Lear P A; Heidecke C D; Kupiec-Weglinski J W; Araneda D; Strom T B; Tilney N L
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine.
Transplantation 1983;36(4):412-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Terry Strom

Research Profile (preview)

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Terry Strom (preview)

All Publications